BenevolentAI achieves second major collaboration milestone wit...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LONDON, Dec. 15, 2021 /PRNewswire-AsiaNet/ -- - Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca- Announcement represents the second collaboration milestone following the addition of a...
Authors: LATEST ASIANET NEWS RELEASES